Symbol
FATE on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned
2,274,020 shares
Security Ownership %
2%
Shares, Excluding Options vs Price
Value, Excluding Options

THE GOLDMAN SACHS GROUP, INC. ownership in FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE)

14 Aug 2025 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,274,020 shares of FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE). This represents 2% ownership of the company. In their previous filing dated 09 May 2025, GOLDMAN SACHS GROUP INC had reported owning 8,487,220 shares, indicating a decrease of +73%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.